Cite
HARVARD Citation
Zhang, H. et al. (2018). MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription. Tumori. 104 (3), pp. 221-231. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, H. et al. (2018). MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription. Tumori. 104 (3), pp. 221-231. [Online].